Subtype
Adrenal Gland Neoplasm
CI-CAN-00000413Explore in graph →
Non-malignant54 active trials1 approved drugs4 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000413Explore in graph →
Clinical trials
262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04785287 | Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies | terminated | Phase 1 / Phase 2 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT03165721 | A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer | terminated | Phase 2 | 9 | National Cancer Institute (NCI)NIH |
| 1 |
| Feb 18, 2026 |
| clinicaltrials |
| NCT04187404 | A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma(Spencer) | terminated | Phase 1 / Phase 2 | 70 | EnteromeINDUSTRY | 8 | Jan 30, 2026 | clinicaltrials |
| NCT03746431 | A Phase 1 Study of [225Ac]-FPI-1434 Injection | terminated | Phase 1 | 78 | Fusion Pharmaceuticals Inc.INDUSTRY | 3 | Jan 7, 2026 | clinicaltrials |
| NCT05634577 | A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma | terminated | Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT02010957 | Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia(FAMIAN) | terminated | Phase 3 | 85 | Wuerzburg University HospitalOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT05999292 | Phase 1 Study of 68Ga-R8760 | terminated | Phase 1 | 11 | Radionetics OncologyINDUSTRY | 1 | Dec 9, 2024 | clinicaltrials |
| NCT05012397 | Milademetan in Advanced/Metastatic Solid Tumors | terminated | Phase 2 | 40 | Rain Oncology IncINDUSTRY | 1 | Oct 17, 2024 | clinicaltrials |
| NCT04605848 | Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT)(MICROBAT) | terminated | N/A | 7 | University of AvignonOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT01246739 | Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome(AUSC) | terminated | N/A | 34 | Region SkaneOTHER | 3 | Apr 10, 2024 | clinicaltrials |
| NCT05456997 | Metabolic Myopathy in Endocrinopathy(LYDIA) | terminated | — | 1 | Barts & The London NHS TrustOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT05948137 | F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma | terminated | — | 32 | Asan Medical CenterOTHER | 1 | Jul 17, 2023 | clinicaltrials |
| NCT03986593 | Cryoablation of Bone Metastases From Endocrine Tumors | terminated | N/A | 17 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT04447014 | Natural History Study of Children and Adults With Adrenocortical Cancer (ACC) | terminated | — | 15 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2023 | clinicaltrials |
| NCT01086696 | A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers | terminated | Early Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT02720484 | Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer | terminated | Phase 2 | 10 | Northwestern UniversityOTHER | 1 | May 1, 2019 | clinicaltrials |
| NCT01348698 | Evaluation of Molecular Markers in Adrenal Tumors | terminated | — | 74 | National Cancer Institute (NCI)NIH | 1 | Nov 26, 2018 | clinicaltrials |
| NCT02001051 | Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism | terminated | Phase 2 | 4 | National Cancer Institute (NCI)NIH | 1 | Jun 14, 2018 | clinicaltrials |
| NCT00003453 | Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer | terminated | Phase 2 | 6 | Burzynski Research InstituteOTHER | 1 | May 9, 2018 | clinicaltrials |
| NCT01340794 | Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma | terminated | Phase 2 | 7 | National Cancer Institute (NCI)NIH | 3 | Sep 21, 2017 | clinicaltrials |
| NCT00947167 | A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors | terminated | Phase 2 | 4 | Pamela L. KunzOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01832974 | Possible New Therapy for Advanced Cancer | terminated | Phase 1 | 9 | INSYS Therapeutics IncINDUSTRY | 1 | Apr 27, 2015 | clinicaltrials |
| NCT00002947 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated | Phase 1 | 35 | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00778817 | IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery | terminated | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2014 | clinicaltrials |
| NCT00911729 | Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma | terminated | — | 24 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 10, 2013 | clinicaltrials |
| NCT00002921 | S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery | terminated | Phase 2 | 13 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00466856 | Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors | terminated | Phase 2 | 10 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Mar 3, 2026source: clinicaltrials